Marimedic: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Marimedic
Largest movements
- Tangible fixed assets -€8,551
down €8,551 (-41.6%), from €20,538 to €11,987
of which Furniture and vehicles: -€7,855
- Receivables within one year -€3,328
down €3,328 (-90.8%), from €3,666 to €338
- Cash -€2,328
down €2,328 (-1.2%), from €190,998 to €188,669
mainly Contributions, distributions and other (-€120,000) and Smaller working-capital items (-€224)
- Profit (loss) carried forward -€20,859
down €20,859 (-10.8%), from €193,480 to €172,621
- Tax, wage and social debts +€6,876
up €6,876 (+275.0%), from €2,500 to €9,376
of which Taxes: +€6,876
- Gross operating margin +€37,363
up €37,363 (+38.1%), from €98,018 to €135,380
- Taxes +€8,680
up €8,680 (+47.7%), from €18,196 to €26,876
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €216,711 | €202,547 | -€14,164 | -6.5% |
| Fixed assets | 21/28 | €20,788 | €12,237 | -€8,551 | -41.1% |
| Tangible fixed assets | 22/27 | €20,538 | €11,987 | -€8,551 | -41.6% |
| Plant, machinery and equipment | 23 | €3,278 | €2,581 | -€696 | -21.2% |
| Furniture and vehicles | 24 | €17,260 | €9,406 | -€7,855 | -45.5% |
| Financial fixed assets | 28 | €250 | €250 | = | 0.0% |
| Current assets | 29/58 | €195,923 | €190,309 | -€5,613 | -2.9% |
| Amounts receivable within one year | 40/41 | €3,666 | €338 | -€3,328 | -90.8% |
| Other amounts receivable | 41 | €3,666 | €338 | -€3,328 | -90.8% |
| Cash at bank and in hand | 54/58 | €190,998 | €188,669 | -€2,328 | -1.2% |
| Deferred charges and accrued income | 490/1 | €1,259 | €1,302 | +€43 | +3.4% |
| Total equity and liabilities | 10/49 | €216,711 | €202,547 | -€14,164 | -6.5% |
| Equity | 10/15 | €194,480 | €173,621 | -€20,859 | -10.7% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €193,480 | €172,621 | -€20,859 | -10.8% |
| Amounts payable | 17/49 | €22,231 | €28,925 | +€6,694 | +30.1% |
| Amounts payable within one year | 42/48 | €22,053 | €28,925 | +€6,872 | +31.2% |
| Trade debts | 44 | €1,337 | €1,314 | -€23 | -1.7% |
| Suppliers | 440/4 | €1,337 | €1,314 | -€23 | -1.7% |
| Taxes, remuneration and social security | 45 | €2,500 | €9,376 | +€6,876 | +275.0% |
| Taxes | 450/3 | - | €6,876 | +€6,876 | |
| Remuneration and social security | 454/9 | €2,500 | €2,500 | = | 0.0% |
| Other amounts payable | 47/48 | €18,216 | €18,236 | +€20 | +0.1% |
| Accrued charges and deferred income | 492/3 | €178 | - | -€178 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €7,332 | €8,551 | +€1,218 | +16.6% |
| Other operating charges | 640/8 | €505 | €768 | +€262 | +51.9% |
| Gross operating margin | 9900 | €98,018 | €135,380 | +€37,363 | +38.1% |
| Operating profit (loss) | 9901 | €90,180 | €126,062 | +€35,882 | +39.8% |
| Financial charges | 65/66B | €63 | €45 | -€18 | -28.0% |
| Recurring financial charges | 65 | €63 | €45 | -€18 | -28.0% |
| Profit (loss) for the period before taxes | 9903 | €90,118 | €126,017 | +€35,899 | +39.8% |
| Income taxes | 67/77 | €18,196 | €26,876 | +€8,680 | +47.7% |
| Profit (loss) for the period | 9904 | €71,922 | €99,141 | +€27,220 | +37.8% |
| Profit (loss) for the period to be appropriated | 9905 | €71,922 | €99,141 | +€27,220 | +37.8% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.